“Rescue” abciximab for complicated percutaneous transluminal coronary angioplasty
- 15 September 1998
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 82 (6) , 800-803
- https://doi.org/10.1016/s0002-9149(98)00459-7
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Use of anti-GP IIb-IIIa in acute thrombosis after intracoronary stent implantationCatheterization and Cardiovascular Diagnosis, 1998
- Evidence for Prevention of Death and Myocardial Infarction With Platelet Membrane Glycoprotein IIb/IIIa Receptor Blockade by Abciximab (c7E3 Fab) Among Patients With Unstable Angina Undergoing Percutaneous Coronary RevascularizationJournal of the American College of Cardiology, 1997
- Platelet Glycoprotein IIb/IIIa Receptor Blockade and Low-Dose Heparin during Percutaneous Coronary RevascularizationNew England Journal of Medicine, 1997
- Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE studyThe Lancet, 1997
- Restoration of Coronary Flow in Myocardial Infarction by Intravenous Chimeric 7E3 Antibody Without Exogenous Plasminogen ActivatorsCirculation, 1997
- Effects of GP IIb/IIIa Receptor Monoclonal Antibody (7E3), Heparin, and Aspirin in an Ex Vivo Canine Arteriovenous Shunt Model of Stent ThrombosisCirculation, 1997
- Blockade of Platelet GPIIb/IIIa Receptors as an Antithrombotic StrategyCirculation, 1995
- Percutaneous Transluminal Coronary AngioplastyNew England Journal of Medicine, 1994
- Use of a Monoclonal Antibody Directed against the Platelet Glycoprotein IIb/IIIa Receptor in High-Risk Coronary AngioplastyNew England Journal of Medicine, 1994
- Platelet activation during coronary angioplasty in humans.Circulation, 1993